Fernando
Lecanda Cordero
Profesional Investigador
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (1)
1998
-
Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation
Journal of Bone and Mineral Research, Vol. 13, Núm. 4, pp. 633-644